Table 1 Demographic and baseline characteristics of the study cohort divided into patients that received neoadjuvant chemotherapy and radical hysterectomy (NACTRH) or chemo-radiotherapy (CRT)
Group | |||
|---|---|---|---|
NACTRH (n = 46) | CRT (n = 51) | P value | |
Age, year, Median (SD) | 46.41 (10.8) | 53.06 (11.02) | 0.004 |
Gravid, Median (IQR) | 3 (1–3) | 2 (1–3) | 0.93 |
Fallow up time, year, Median (IQR) | 3.85 (3.48–4.3) | 3.2 (2.8–3.7) | < 0.001 |
Stage, n (%) | |||
IB3 | 29 (63) | 21 (41.2) | 0.03 |
IIA2 | 17 (37) | 30 (58.8) | |
Surgery complications, n (%) | 6 (13) | – | NA |
Chemotherapy complications, n (%) | 6 (13) | 10 (19.6) | 0.38 |
Chemo-radiotherapy complications, n (%) | – | 12 (23.5) | NA |